Emerging Infectious Diseases (Sep 2023)

Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France

  • Agnès B. Jousset,
  • Laura Bouabdallah,
  • Aurélien Birer,
  • Isabelle Rosinski-Chupin,
  • Jean-François Mariet,
  • Saoussen Oueslati,
  • Cécile Emeraud,
  • Delphine Girlich,
  • Philippe Glaser,
  • Thierry Naas,
  • Rémy A. Bonnin,
  • Laurent Dortet

DOI
https://doi.org/10.3201/eid2909.230390
Journal volume & issue
Vol. 29, no. 9
pp. 1877 – 1881

Abstract

Read online

Cefiderocol resistance is increasingly reported in New Delhi metallo-β-lactamase–producing Enterobacterales. Genomic and phenotypic analysis of Escherichia coli sequence type 361, a primary clone causing carbapenemase spread in France, revealed mutations leading to cefiderocol resistance. Continued genomic surveillance of carbapenem-resistant Enterobacterales could clarify prevalence of cefiderocol-resistant E. coli in Europe.

Keywords